skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:066643/0549   Pages: 30
Recorded: 02/21/2024
Attorney Dkt #:395591-00011
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 37
1
Patent #:
NONE
Issue Dt:
Application #:
12301021
Filing Dt:
06/04/2009
Publication #:
US20100196336
Pub Dt:
08/05/2010
Title:
MODIFIED DENDRITIC CELLS HAVING ENHANCED SURVIVAL AND IMMUNOGENICITY AND RELATED COMPOSITIONS AND METHODS
2
Patent #:
NONE
Issue Dt:
Application #:
12301021
Filing Dt:
06/04/2009
Publication #:
US20100196336
Pub Dt:
08/05/2010
PCT #:
US0769586
Title:
MODIFIED DENDRITIC CELLS HAVING ENHANCED SURVIVAL AND IMMUNOGENICITY AND RELATED COMPOSITIONS AND METHODS
3
Patent #:
NONE
Issue Dt:
Application #:
13087329
Filing Dt:
04/14/2011
Publication #:
US20110287038
Pub Dt:
11/24/2011
Title:
METHOD FOR TREATING PROSTATE CANCER USING MODIFIED ANTIGEN-PRESENTING CELLS THAT EXPRESS INDUCIBLE CD40 POLYPEPTIDES
4
Patent #:
8486693
Issue Dt:
07/16/2013
Application #:
13622501
Filing Dt:
09/19/2012
Publication #:
US20130130386
Pub Dt:
05/23/2013
Title:
MODIFIED DENDRITIC CELLS HAVING ENHANCED SURVIVAL AND IMMUNOGENICITY AND RELATED COMPOSITIONS AND METHODS
5
Patent #:
NONE
Issue Dt:
Application #:
13786652
Filing Dt:
03/06/2013
Publication #:
US20140023647
Pub Dt:
01/23/2014
Title:
METHODS FOR TREATING PROSTATE CANCER USING NUCLEIC ACID COMPOSITIONS
6
Patent #:
9434935
Issue Dt:
09/06/2016
Application #:
13792135
Filing Dt:
03/10/2013
Publication #:
US20140255360
Pub Dt:
09/11/2014
Title:
MODIFIED CASPASE POLYPEPTIDES AND USES THEREOF
7
Patent #:
9944690
Issue Dt:
04/17/2018
Application #:
14210034
Filing Dt:
03/13/2014
Publication #:
US20140286987
Pub Dt:
09/25/2014
Title:
METHODS FOR CONTROLLING T CELL PROLIFERATION
8
Patent #:
9913882
Issue Dt:
03/13/2018
Application #:
14296404
Filing Dt:
06/04/2014
Publication #:
US20160151465
Pub Dt:
06/02/2016
Title:
METHODS FOR INDUCING PARTIAL APOPTOSIS USING CASPASE POLYPEPTIDES
9
Patent #:
10934346
Issue Dt:
03/02/2021
Application #:
14622018
Filing Dt:
02/13/2015
Publication #:
US20160046700
Pub Dt:
02/18/2016
Title:
MODIFIED T CELL COMPRISING A POLYNUCLEOTIDE ENCODING AN INDUCIBLE STIMULATING MOLECULE COMPRISING MyD88, CD40 AND FKBP12
10
Patent #:
NONE
Issue Dt:
Application #:
14640553
Filing Dt:
03/06/2015
Publication #:
US20150328292
Pub Dt:
11/19/2015
Title:
CASPASE POLYPEPTIDES HAVING MODIFIED ACTIVITY AND USES THEREOF
11
Patent #:
10888608
Issue Dt:
01/12/2021
Application #:
14842710
Filing Dt:
09/01/2015
Publication #:
US20160058857
Pub Dt:
03/03/2016
Title:
COSTIMULATION OF CHIMERIC ANTIGEN RECEPTORS BY MYD88 AND CD40 POLYPEPTIDES
12
Patent #:
NONE
Issue Dt:
Application #:
14968737
Filing Dt:
12/14/2015
Publication #:
US20160166613
Pub Dt:
06/16/2016
Title:
METHODS FOR CONTROLLED ELIMINATION OF THERAPEUTIC CELLS
13
Patent #:
NONE
Issue Dt:
Application #:
14968853
Filing Dt:
12/14/2015
Publication #:
US20160175359
Pub Dt:
06/23/2016
Title:
METHODS FOR CONTROLLED ACTIVATION OR ELIMINATION OF THERAPEUTIC CELLS
14
Patent #:
9932572
Issue Dt:
04/03/2018
Application #:
15224441
Filing Dt:
07/29/2016
Publication #:
US20170015987
Pub Dt:
01/19/2017
Title:
MODIFIED CASPASE POLYPEPTIDES AND USES THEREOF
15
Patent #:
NONE
Issue Dt:
Application #:
15377776
Filing Dt:
12/13/2016
Publication #:
US20170166877
Pub Dt:
06/15/2017
Title:
DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION
16
Patent #:
10525110
Issue Dt:
01/07/2020
Application #:
15888948
Filing Dt:
02/05/2018
Publication #:
US20180243384
Pub Dt:
08/30/2018
Title:
METHODS FOR INDUCING PARTIAL APOPTOSIS USING CASPASE POLYPEPTIDES
17
Patent #:
NONE
Issue Dt:
Application #:
15901556
Filing Dt:
02/21/2018
Publication #:
US20180251746
Pub Dt:
09/06/2018
Title:
MODIFIED CASPASE POLYPEPTIDES AND USES THEREOF
18
Patent #:
NONE
Issue Dt:
Application #:
15910380
Filing Dt:
03/02/2018
Publication #:
US20180265566
Pub Dt:
09/20/2018
Title:
METHODS FOR CONTROLLING T CELL PROLIFERATION
19
Patent #:
NONE
Issue Dt:
Application #:
16611772
Filing Dt:
11/07/2019
Publication #:
US20210147507
Pub Dt:
05/20/2021
Title:
METHODS TO AUGMENT OR ALTER SIGNAL TRANSDUCTION
20
Patent #:
NONE
Issue Dt:
Application #:
16611772
Filing Dt:
11/07/2019
Publication #:
US20210147507
Pub Dt:
05/20/2021
PCT #:
US1831689
Title:
METHODS TO AUGMENT OR ALTER SIGNAL TRANSDUCTION
21
Patent #:
11839647
Issue Dt:
12/12/2023
Application #:
16734104
Filing Dt:
01/03/2020
Publication #:
US20200230216
Pub Dt:
07/23/2020
Title:
METHODS FOR INDUCING PARTIAL APOPTOSIS USING CASPASE POLYPEPTIDES
22
Patent #:
NONE
Issue Dt:
Application #:
16770019
Filing Dt:
06/04/2020
Publication #:
US20200347148
Pub Dt:
11/05/2020
Title:
METHODS FOR ENHANCING AND MAINTAINING CAR-T CELL EFFICACY
23
Patent #:
NONE
Issue Dt:
Application #:
16770019
Filing Dt:
06/04/2020
Publication #:
US20200347148
Pub Dt:
11/05/2020
PCT #:
US1864568
Title:
METHODS FOR ENHANCING AND MAINTAINING CAR-T CELL EFFICACY
24
Patent #:
10918705
Issue Dt:
02/16/2021
Application #:
16788062
Filing Dt:
02/11/2020
Publication #:
US20200237886
Pub Dt:
07/30/2020
Title:
COSTIMULATION OF CHIMERIC ANTIGEN RECEPTORS BY MYD88 AND CD40 POLYPEPTIDES
25
Patent #:
NONE
Issue Dt:
Application #:
16955693
Filing Dt:
06/18/2020
Publication #:
US20200308144
Pub Dt:
10/01/2020
Title:
Multimeric piperidine derivatives
26
Patent #:
NONE
Issue Dt:
Application #:
16955693
Filing Dt:
06/18/2020
Publication #:
US20200308144
Pub Dt:
10/01/2020
PCT #:
US1866532
Title:
Multimeric piperidine derivatives
27
Patent #:
NONE
Issue Dt:
Application #:
17053275
Filing Dt:
11/05/2020
Publication #:
US20210107966
Pub Dt:
04/15/2021
Title:
NATURAL KILLER CELL PRODUCTS AND METHODS
28
Patent #:
NONE
Issue Dt:
Application #:
17053275
Filing Dt:
11/05/2020
Publication #:
US20210107966
Pub Dt:
04/15/2021
PCT #:
US1930939
Title:
NATURAL KILLER CELL PRODUCTS AND METHODS
29
Patent #:
NONE
Issue Dt:
Application #:
17114398
Filing Dt:
12/07/2020
Publication #:
US20210346477
Pub Dt:
11/11/2021
Title:
COSTIMULATION OF CHIMERIC ANTIGEN RECEPTORS BY MYD88 AND CD40 POLYPEPTIDES
30
Patent #:
NONE
Issue Dt:
Application #:
17176841
Filing Dt:
02/16/2021
Publication #:
US20220025024
Pub Dt:
01/27/2022
Title:
METHODS FOR ACTIVATING T CELLS USING AN INDUCIBLE CHIMERIC POLYPEPTIDE
31
Patent #:
NONE
Issue Dt:
Application #:
17219116
Filing Dt:
03/31/2021
Publication #:
US20230065562
Pub Dt:
03/02/2023
Title:
DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION
32
Patent #:
NONE
Issue Dt:
Application #:
17288845
Filing Dt:
04/26/2021
Publication #:
US20220002674
Pub Dt:
01/06/2022
Title:
T CELLS WITH SUICIDE SWITCH
33
Patent #:
NONE
Issue Dt:
Application #:
17288845
Filing Dt:
04/26/2021
Publication #:
US20220002674
Pub Dt:
01/06/2022
PCT #:
US1958664
Title:
T CELLS WITH SUICIDE SWITCH
34
Patent #:
NONE
Issue Dt:
Application #:
17343071
Filing Dt:
06/09/2021
Publication #:
US20220125837
Pub Dt:
04/28/2022
Title:
METHODS FOR CONTROLLED ELIMINATION OF THERAPEUTIC CELLS
35
Patent #:
NONE
Issue Dt:
Application #:
17353587
Filing Dt:
06/21/2021
Publication #:
US20220152100
Pub Dt:
05/19/2022
Title:
METHODS FOR CONTROLLED ACTIVATION OR ELIMINATION OF THERAPEUTIC CELLS
36
Patent #:
NONE
Issue Dt:
Application #:
17632118
Filing Dt:
02/01/2022
Publication #:
US20220273717
Pub Dt:
09/01/2022
Title:
IMPROVED FORMULATIONS FOR IMMUNE CELLS
37
Patent #:
NONE
Issue Dt:
Application #:
17632118
Filing Dt:
02/01/2022
Publication #:
US20220273717
Pub Dt:
09/01/2022
PCT #:
US2045999
Title:
IMPROVED FORMULATIONS FOR IMMUNE CELLS
Assignor
1
BELLICUM PHARMACEUTICALS, INC.
Exec Dt:
11/21/2023
Assignee
1
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
210 WEST 7TH STREET
AUSTIN, TEXAS 78701
Correspondence name and address
SEAN S. WOODEN
1919 PENNSYLVANIA AVENUE, NW #800
WASHINGTON, DC 20006

Search Results as of: 05/24/2024 05:10 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT